Home | Articles
Published on:September 2022
Indian Journal of Pharmaceutical Education and Research, 2022; 56(3s):s413-s421
Original Article | doi:10.5530/ijper.56.3s.149

Formulation and Evaluation of Oral Trans-mucosal Delivery System of Eletriptan Hydrobromide


Authors and affiliation (s):

Manan Patel1,*, Radhika Pandya2

1Department of Pharmaceutics, SAL Institute of Pharmacy, Ahmedabad, Gujarat, INDIA.

2Department of Pharmaceutics and Pharmaceutical Technology, L. M. College of Pharmacy, Ahmedabad, Gujarat, INDIA.

Abstract:

Background: To formulate, develop and evaluate sublingual tablet of anti-migraine agent (Eletriptan Hydrobromide). Materials and Methods: The sublingual tablet was prepared by direct compression method and the tablets were formulated using Kyron T-314, Sodium Bicarbonate, Mannitol, Neusilin US2, Stevia, PVP K-30, Magnesium Stearate and Talc as excipients. The prepared tablets were evaluated for various parameters like hardness, thickness, friability, weight variation, wetting time, in vitro disintegration time, in vitro dissolution and ex-vivo permeation study. A 32 full factorial design was applied to optimize the concentration of Kyron T-314(X1) and Sodium Bicarbonate (X2). Disintegration time (Y1) and % drug release at 15 min (Y2) were taken as dependent variables. Results: From the all batches, B9 was found to be the best batch with 3.5% of Kyron T-314 and 40% Sodium Bicarbonate. The optimized batch gave the best disintegration time of 9 sec and % drug release of 92.23% in 15 min. It showed maximum permeation of 93.17% in 30 min which is significant compared to the formulation without alkalizing agent. Conclusion: This indicates that the amount of the drug which remains unionised after the addition of the alkalizing agent lead to increase in permeability. Stability testing of the optimised batch was carried out and the results showed no significant change in the results of % drug release.

Key words: Anti-Migraine, Alkalizing agent, Permeation, Sublingual, Eletriptan Hydrobromide.

 




 

Impact Factor

IJPER - An Official Publication of Association of Pharmaceutical Teachers of India is pleased to announce continued growth in the Latest Release of Journal Citation Reports (source: Web of Science Data).

 

Impact Factor® as reported in the 2023 Journal Citation Reports® (Clarivate Analytics, 2023): 0.8

The Official Journal of Association of Pharmaceutical Teachers of India (APTI)
(Registered under Registration of Societies Act XXI of 1860 No. 122 of 1966-1967, Lucknow)

Indian Journal of Pharmaceutical Education and Research (IJPER) [ISSN-0019-5464] is the official journal of Association of Pharmaceutical Teachers of India (APTI) and is being published since 1967.

DOI HISTORY

IJPER uses reference linking service using Digital Object Identifiers (DOI) by Crossref. Articles from the year 2013 are being assigned DOIs for its permanent URLs